Recruiting nowPhase 3
Effect of Metformin Use on Weight Loss in Obese, Non-diabetic People (MOWRI)
Updated 2025-12-22 · NCT07297290See eligibility →
Country
Active obesity and GLP-1 studies with at least one location in Nigeria.
Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.
The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.
No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.